ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,054Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 4623

$1.66M Total Retail Price of All Prescriptions

Rank: 26 out of 4623

667 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 667 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

22% of this provider’s 667 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 19,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 819 669 1 1
SIMVASTATIN 816 653 2 2
FUROSEMIDE 734 634 3 8
HYDROCODONE-ACETAMINOPHEN 714 485 S3 4 3
AMLODIPINE BESYLATE 659 576 5 5
LISINOPRIL 599 474 6 4
TRAZODONE HCL 564 476 7 42
DONEPEZIL HCL 554 519 8 30
NAMENDA 552 537 9 36
OMEPRAZOLE 417 340 10 7
EXELON 354 329 11 107
CITALOPRAM HBR 330 255 12 23
SERTRALINE HCL 325 290 13 26
METOPROLOL TARTRATE 311 291 14 9
METFORMIN HCL 307 239 15 6
POTASSIUM CHLORIDE 307 275 15 14
FAMOTIDINE 295 275 17 82
HYDROCHLOROTHIAZIDE 291 269 18 10
RISPERIDONE 291 284 18 72
ZOLPIDEM TARTRATE 286 193 20 18
ATORVASTATIN CALCIUM 272 238 21 12
CYMBALTA 265 186 22 48
CLOPIDOGREL 255 226 23 31
METOPROLOL SUCCINATE 250 230 24 13
MIRTAZAPINE 244 238 25 57
LANTUS 237 191 26 44
HUMALOG 196 150 27 186
TRAMADOL HCL 185 127 28 15
METFORMIN HCL ER 181 133 29 51
CRESTOR 179 146 30 20
NAPROXEN 167 104 31 63
LOSARTAN POTASSIUM 165 127 32 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 163 130 33 19
ESCITALOPRAM OXALATE 162 141 34 75
KLOR-CON M20 158 117 35 102
PRAVASTATIN SODIUM 155 129 36 11
GABAPENTIN 152 105 37 16
PLAVIX 152 143 37 45
WARFARIN SODIUM 147 145 39 24
PANTOPRAZOLE SODIUM 147 122 39 35
KLOR-CON M10 144 137 41 137
RAMIPRIL 144 143 41 76
OLANZAPINE 142 116 43 127
LYRICA 135 116 44 66
ZETIA 134 100 45 92
NITROGLYCERIN PATCH 132 132 46 190
ALENDRONATE SODIUM 130 120 47 22
NITROFURANTOIN MONO-MACRO 129 113 48 172
SYNTHROID 123 116 49 73
TAMSULOSIN HCL 122 112 50 29
DIGOXIN 121 115 51 58
DIVALPROEX SODIUM 121 97 51 90
NOVOLOG 120 115 53 123
NEXIUM 110 96 54 17
CARISOPRODOL 109 11 R 55 71
FLUTICASONE PROPIONATE 109 60 55 32
TRAMADOL HCL-ACETAMINOPHEN 104 96 57 103
CARVEDILOL 102 79 58 25
JANUVIA 102 64 58 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 99 89 60 68
ATENOLOL 99 79 60 28
MELOXICAM 99 66 60 27
CLONIDINE HCL 98 75 63 40
CARBIDOPA-LEVODOPA 98 98 63 116
LOSARTAN-HYDROCHLOROTHIAZIDE 97 83 65 46
FENOFIBRATE 96 85 66 54
CELEBREX 93 64 67 89
ACTOS 93 71 67 87
CYCLOBENZAPRINE HCL 87 32 R 69 53
ISOSORBIDE MONONITRATE ER 84 77 70 60
GLIMEPIRIDE 83 79 71 38
SPIRIVA 82 56 72 79
OXYBUTYNIN CHLORIDE ER 81 49 73 163
SPIRONOLACTONE 81 60 73 77
VENLAFAXINE HCL ER 80 53 75 132
SINGULAIR 79 45 76 83
METOCLOPRAMIDE HCL 79 72 76 126
PROMETHAZINE HCL 79 50 R 76 93
ADVAIR DISKUS 79 40 76 62
DIOVAN 77 73 80 39
ALLOPURINOL 77 58 80 37
CIPROFLOXACIN HCL 70 53 82 43
AGGRENOX 69 57 83 198
ABILIFY 69 56 83 161
DIVALPROEX SODIUM ER 68 21 85 148
LANTUS SOLOSTAR 66 37 86 105
PAROXETINE HCL 65 64 87 78
AMOX TR-POTASSIUM CLAVULANATE 65 46 87 117
LUNESTA 65 28 87 287
MONTELUKAST SODIUM 64 38 90 158
AZITHROMYCIN 64 45 90 33
AMITRIPTYLINE HCL 64 31 R 90 69
ENALAPRIL MALEATE 62 49 93 41
ROPINIROLE HCL 61 52 94 108
PRAMIPEXOLE DIHYDROCHLORIDE 60 46 95 218
LATANOPROST 60 60 95 224
QUETIAPINE FUMARATE 59 48 97 74
LEVOFLOXACIN 58 45 98 81
CLOTRIMAZOLE-BETAMETHASONE 56 42 99 147
RANITIDINE HCL 56 48 99 47
HYDROXYZINE HCL 55 55 R 101 138
METHADONE HCL 55 14 S2 101 193
GLYBURIDE 54 29 R 103 59
VESICARE 54 54 103 166
PREDNISONE 52 36 105 50
TRIAMTERENE-HCTZ 52 46 105 80
IBUPROFEN 51 27 107 65
MUPIROCIN 51 43 107 159
PHENYTOIN SODIUM EXTENDED 51 51 107 119
NIFEDIPINE ER 50 33 110 97
LOVASTATIN 50 47 110 34
BRIMONIDINE TARTRATE 50 50 110 398
LACTULOSE 50 37 110 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.